UTime Limited (NASDAQ: WTO), a prominent player in the healthcare sector, has officially signed a non-disclosure agreement (NDA) to acquire Bowen Therapeutics Inc, including its laboratory at UMASS Medical School. This significant development underscores UTime’s commitment to expanding its presence in the global vaccine market and advancing the registration of an innovative monkeypox vaccine with […]
Dynavax Technologies Corporation, a renowned player in the biopharmaceutical sector, has made headlines with the initiation of a Phase 1/2 clinical trial for its innovative shingles vaccine candidate, Z-1018. This trial marks a significant step in the development of a vaccine aimed at preventing shingles, a painful condition caused by the reactivation of the varicella-zoster […]
Sun Pharma, an Indian multinational pharmaceutical company, has announced a collaboration with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a new dengue vaccine aimed at being safer, more effective, and more affordable than existing vaccines. This initiative marks the second collaboration between Sun Pharma and ICGEB, building on their earlier partnership […]